| A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils B Geering, U Gurzeler, E Federzoni, T Kaufmann, HU Simon Blood, The Journal of the American Society of Hematology 117 (22), 5953-5962, 2011 | 102 | 2011 |
| Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy E Grassilli, R Narloch, E Federzoni, L Ianzano, F Pisano, R Giovannoni, ... Clinical Cancer Research 19 (14), 3820-3831, 2013 | 98 | 2013 |
| MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma SI Rothschild, MP Tschan, EA Federzoni, R Jaggi, MF Fey, M Gugger, ... Oncogene 31 (38), 4221-4232, 2012 | 91 | 2012 |
| Low autophagy (ATG) gene expression is associated with an immature AML blast cell phenotype and can be restored during AML differentiation therapy J Jin, A Britschgi, AM Schläfli, M Humbert, D Shan-Krauer, J Batliner, ... Oxidative medicine and cellular longevity 2018, 2018 | 63 | 2018 |
| PU. 1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells EA Federzoni, PJM Valk, BE Torbett, T Haferlach, B Löwenberg, MF Fey, ... Blood, The Journal of the American Society of Hematology 119 (21), 4963-4970, 2012 | 61 | 2012 |
| CEBPA-dependent HK3 and KLF5 expression in primary AML and during AML differentiation EA Federzoni, M Humbert, BE Torbett, G Behre, MF Fey, MP Tschan Scientific reports 4 (1), 4261, 2014 | 40 | 2014 |
| The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU. 1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL M Humbert, EA Federzoni, A Britschgi, AM Schläfli, PJM Valk, T Kaufmann, ... Journal of leukocyte biology 95 (1), 83-93, 2014 | 37 | 2014 |
| The RNA binding proteins RBM38 and DND1 are repressed in AML and have a novel function in APL differentiation J Wampfler, EA Federzoni, BE Torbett, MF Fey, MP Tschan Leukemia research 41, 96-102, 2016 | 32 | 2016 |
| Human DMTF1β antagonizes DMTF1α regulation of the p14ARF tumor suppressor and promotes cellular proliferation MP Tschan, EA Federzoni, A Haimovici, C Britschgi, BA Moser, J Jin, ... Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1849 (9 …, 2015 | 24 | 2015 |
| PU. 1 supports TRAIL-induced cell death by inhibiting NF-κB-mediated cell survival and inducing DR5 expression A Haimovici, M Humbert, EA Federzoni, D Shan-Krauer, T Brunner, ... Cell Death & Differentiation 24 (5), 866-877, 2017 | 22 | 2017 |
| Hexokinase 3 enhances myeloid cell survival via non-glycolytic functions K Seiler, M Humbert, P Minder, I Mashimo, AM Schläfli, D Krauer, ... Cell death & disease 13 (5), 448, 2022 | 21 | 2022 |
| Transcriptional regulation of MIR29B by PU. 1 (SPI1) and MYC during neutrophil differentiation of acute promyelocytic leukaemia cells. J Batliner, E Buehrer, EA Federzoni, M Jenal, A Tobler, BE Torbett, ... British journal of haematology 157 (2), 2012 | 20 | 2012 |
| Distinct TP73–DAPK2–ATG5 pathway involvement in ATO-mediated cell death versus ATRA-mediated autophagy responses in APL M Humbert, EA Federzoni, MP Tschan Journal of leukocyte biology 102 (6), 1357-1370, 2017 | 19 | 2017 |
| Protein overexpression following lentiviral infection of primary mature neutrophils is due to pseudotransduction B Geering, J Schmidt-Mende, E Federzoni, C Stoeckle, HU Simon Journal of immunological methods 373 (1-2), 209-218, 2011 | 14 | 2011 |
| Low DICER1 expression is associated with attenuated neutrophil differentiation and autophagy of NB4 APL cells J Wampfler, EA Federzoni, BE Torbett, MF Fey, MP Tschan Journal of Leucocyte Biology 98 (3), 357-363, 2015 | 9 | 2015 |
| The actin-binding protein CORO1A is a novel PU. 1 (SPI1)-and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients. EA Federzoni, M Humbert, PJM Valk, G Behre, EO Leibundgut, BE Torbett, ... British journal of haematology 160 (6), 2013 | 6 | 2013 |
| Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells EA Federzoni, S Gloor, J Jin, D Shan-Krauer, MF Fey, BE Torbett, ... Leukemia research reports 4 (1), 32-35, 2015 | 4 | 2015 |
| Abstract B113: GSK3A is redundant with GSK3B in modulating drug resistance and chemotherapy-induced necroptosis. E Grassilli, E Federzoni, R Narloch, L Ianzano, K Helin, M Lavitrano Molecular Cancer Therapeutics 12 (11_Supplement), B113-B113, 2013 | 1 | 2013 |
| A kinase-directed RNAi screen identifies GSK-3b/a as a target to overcome drug resistance of p53-null colon cancer cells E Grassilli, R Narloch, E Federzoni, BE Leone, K Helin, M Lavitrano Clinical Cancer Research 16 (19_Supplement), A5-A5, 2010 | 1 | 2010 |
| Expression of CD95 on mature leukocytes of MRL/lpr mice after transplantation of genetically modified bone marrow stem cells E Federzoni, G Gordon, S Müller, I Schmid, HU Simon, S Yousefi Immunology letters 117 (1), 45-49, 2008 | 1 | 2008 |
Mario P. TschanAssociate Professor, University of BernVerified email at pathology.unibe.ch
